ARTICLE | Company News

Genencor, The Mayo Clinic deal

January 16, 2001 8:00 AM UTC

GCOR said it developed a mouse line expressing the human HLA DR3 and DQ2 genes. GCOR will develop the DQ2:DR3 haplotype mouse with the Mayo Clinic as a model for celiac disease, an autoimmune diseas...